Heron Therapeutics, Inc.

Back to All Transactions

Heron Therapeutics, Inc.
For more information regarding this transaction contact:
  • Dave McDonald Investment Banking 612.326.1268

Lake Street is pleased to announce it served as a co-managing underwriter for Heron Therapeutics, Inc. (Nasdaq:HRTX) in its underwritten public offering of 6,000,000 shares of common stock at an offering price of $26.00 per share. Gross proceeds totaled $156 million.

About Heron Therapeutics, Inc.

Heron Therapeutics, Inc. is a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class medicines that address major unmet medical needs. Heron is developing novel, patient-focused solutions that apply its innovative science and technologies to already-approved pharmacological agents for patients suffering from cancer or pain.


Mike Townley
Head of Investment Banking


Email Mike

Dave McDonald
Head of Life Science Investment Banking


Email Dave


Tim Klein

Investment Banking


Email Tim


Rob Martin

Investment Banking


Email Rob


Steve Rickman

Investment Banking


Email Steve